Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... Using a genome-wide CRISPR knock-out screen, the authors defined the repertoire of genes that are required for proerythroblast survival ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

CRISPR/Cas9 remains the most powerful tool to generate ... To put it in numbers: with their previous vector, a CRISPR screen looking for all double knockouts of just 20 genes was estimated to ...

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

The BRILLIANCE study of EDIT-101 in Leber congenital amaurosis type 10 (LCA10) – an inherited form of blindness – was reported to be the first 'in vivo' CRISPR/Cas9 medicine to be administered ...

The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs ...

Mammalian cell gene editing has extensively used RNA-guided CRISPR-Cas systems, which have shown great promise in the ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.